KIRA WEBER: Open Payments
NPI 1093175895 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 75 payments from 7 companies in 2025. Trend: 2023 $680 · 2024 $955 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 36 | $364 |
| ABBVIE INC. | 19 | $230 |
| UCB, Inc. | 11 | $178 |
| ARGENX US, INC. | 5 | $170 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| InSightec,Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: INGREZZA, UBRELVY, VYVGART, Fintepla, QULIPTA, VYVGART HYTRULO, NUPLAZID, Nayzilam.
Industry payments across LA — which companies pay providers there.
